Literature DB >> 25376208

B cell lymphoma with lung involvement: what is it about?

Michael Mian1, Ines Wasle, Stefan Gritsch, Wolfgang Willenbacher, Michael Fiegl.   

Abstract

Primary lymphoma of the lung or pleural is a very rare condition. Due to the outdated literature data, the approximate occurrence of primary and secondary lung and/or pleural involvement according to the most common B cell lymphoma entities is unknown. To answer this open question in Austria, we screened the Tyrolean registry for B cell non-Hodgkin's lymphomas regarding primary and secondary lung involvement. Of 854 patients affected by B cell lymphoma, 7.5% had lung/pleural disease. This organ was the primary site in only 0.7%, while a secondary involvement was registered in 6.8%. Most of them were affected by diffuse large B cell lymphoma (DLBCL; 29/368, 8%) followed by follicular lymphoma (7/188, 4%), mantle cell lymphoma (7/57, 12%), mucosa-associated tissue lymphoma (10/37, 27%), posttransplant lymphoproliferative disease (6/24, 25%), Burkitt lymphoma (3/19, 16%), other lymphomas (1/32, 3%) and Richter transformation (1/11, 9%). Moreover, primary lung/pleural lymphoma is one of the rarest neoplasias affecting the lung, accounting for only 0.4% of cases. Lung/pleural involvement is a very rare condition among B cell lymphomas since it mainly occurs in the setting of a generalized disease. A large majority of patients with secondary organ involvement are affected by DLBCL and have similar clinical features at diagnosis to others with advanced-stage disease.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25376208     DOI: 10.1159/000365778

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  6 in total

1.  Pleural Effusions in Diffuse Large B-Cell Lymphoma: Clinical and Prognostic Significance.

Authors:  José M Porcel; Irene Cuadrat; Tomás García-Cerecedo; Marina Pardina; Silvia Bielsa
Journal:  Lung       Date:  2018-11-30       Impact factor: 2.584

2.  Ibrutinib resistance in a patient with transformed diffuse large B-cell lymphoma from primary pulmonary mucosa-associated lymphoid tissue lymphoma.

Authors:  Hong Zhou; Li Yang; Qingxiu Dang; Jianfei Huang; Yuehua Cheng; Yaping Zhang; Wenyu Shi
Journal:  Cancer Biol Ther       Date:  2020-01-13       Impact factor: 4.742

3.  Elevated Adenosine Deaminase in Pleural Effusion A Case of Non-Hodgkin Lymphoma Misdiagnosis.

Authors:  Tiago Seco; Ana Margarida Cerqueira; Ana Luís Ferreira; Ana Costa; Carlos Fernandes; Jorge Cotter
Journal:  Eur J Case Rep Intern Med       Date:  2020-05-06

4.  Diffuse Large B-Cell Lymphoma: A Rare Cause of Lung Consolidation.

Authors:  Aditya Jandial; Kundan Mishra; Pranab Dey; Deepak Goni; Mohd Umair; Deepesh Lad; Gaurav Prakash; Alka Khadwal; Neelam Varma; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2018-08-02       Impact factor: 0.900

5.  Misdiagnosis of primary pleural DLBCL as tuberculosis: A case report and literature review.

Authors:  Xinmei Yang; Xiaofang Xu; Binbin Song; Qiang Zhou; Ying Zheng
Journal:  Mol Clin Oncol       Date:  2018-04-02

6.  Phenotypical Characterization and Clinical Outcome of Canine Burkitt-Like Lymphoma.

Authors:  Luca Aresu; Chiara Agnoli; Arturo Nicoletti; Antonella Fanelli; Valeria Martini; Francesco Bertoni; Laura Marconato
Journal:  Front Vet Sci       Date:  2021-03-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.